TP53 and acute myeloid leukemia: Based on these data, we determined the ability of TP-0903 to inhibit these kinases in TP53 mutant AML cell lines including HL-60 (TP53 null), Kasumi-1 (R248Q), and MV4-11 (R248W) cells.